Shares of 89bio, Inc. (NASDAQ:ETNB – Get Rating) were up 3.2% on Tuesday . The company traded as high as $16.26 and last traded at $16.21. Approximately 70,502 shares traded hands during mid-day trading, a decline of 96% from the average daily volume of 1,946,156 shares. The stock had previously closed at $15.70. Analyst Ratings […]
89bio, Inc. (NASDAQ:ETNB – Get Rating)’s stock price was up 7.7% during trading on Monday . The stock traded as high as $16.71 and last traded at $16.71. Approximately 321,227 shares traded hands during mid-day trading, a decline of 84% from the average daily volume of 1,993,399 shares. The stock had previously closed at $15.52. […]
89bio (NASDAQ:ETNB – Get Rating) had its price target upped by Bank of America from $17.00 to $24.00 in a research note issued to investors on Sunday morning, The Fly reports. Several other equities analysts also recently commented on the company. Cantor Fitzgerald upped their target price on 89bio from $34.00 to $45.00 in a […]
89bio, Inc. (NASDAQ:ETNB – Get Rating) CEO Rohan Palekar sold 15,000 shares of 89bio stock in a transaction dated Thursday, March 23rd. The shares were sold at an average price of $16.00, for a total value of $240,000.00. Following the completion of the sale, the chief executive officer now owns 269,080 shares of the company’s […]
89bio (NASDAQ:ETNB – Get Rating) had its price objective hoisted by Bank of America from $17.00 to $24.00 in a research report released on Sunday morning, The Fly reports. Several other equities analysts have also weighed in on ETNB. Oppenheimer raised their price objective on shares of 89bio from $18.00 to $33.00 in a research […]